Cargando…
Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation
BACKGROUND: Osteopontin (OPN), a secreted phosphoglycoprotein, has been strongly associated with tumor progression and aggressive cancers. MDA-MB-435 cells secrete very high levels of OPN. However metastasis-suppressed MDA-MB-435 cells, which were transfected with breast cancer metastasis suppressor...
Autores principales: | Samant, Rajeev S, Clark, David W, Fillmore, Rebecca A, Cicek, Muzaffer, Metge, Brandon J, Chandramouli, Kondethimmana H, Chambers, Ann F, Casey, Graham, Welch, Danny R, Shevde, Lalita A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796551/ https://www.ncbi.nlm.nih.gov/pubmed/17227585 http://dx.doi.org/10.1186/1476-4598-6-6 |
Ejemplares similares
-
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299–5p regulated de novo expression of osteopontin
por: Shevde, Lalita A, et al.
Publicado: (2010) -
Location, location, location: the BRMS1 protein and melanoma progression
por: Riker, Adam I, et al.
Publicado: (2012) -
N-Myc and STAT Interactor regulates autophagy and chemosensitivity in breast cancer cells
por: Metge, Brandon J., et al.
Publicado: (2015) -
Hypoxia re-programs 2′-O-Me modifications on ribosomal RNA
por: Metge, Brandon J., et al.
Publicado: (2020) -
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
por: Elhamamsy, Amr R., et al.
Publicado: (2022)